Cargando…
Enhancing atrial‐specific gene expression using a calsequestrin cis‐regulatory module 4 with a sarcolipin promoter
BACKGROUND: Cardiac gene therapy using the adeno‐associated virus serotype 9 vector is widely used because of its efficient transduction. However, the promoters used to drive expression often cause off‐target localization. To overcome this, studies have applied cardiac‐specific promoters, although e...
Autores principales: | Yoo, Jimeen, Kohlbrenner, Erik, Kim, Okkil, Hajjar, Roger J., Jeong, Dongtak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6519042/ https://www.ncbi.nlm.nih.gov/pubmed/30393908 http://dx.doi.org/10.1002/jgm.3060 |
Ejemplares similares
-
Reducing sarcolipin expression mitigates Duchenne muscular dystrophy and associated cardiomyopathy in mice
por: Voit, Antanina, et al.
Publicado: (2017) -
Cytokine-Like 1 Regulates Cardiac Fibrosis via Modulation of TGF-β Signaling
por: Kim, Jooyeon, et al.
Publicado: (2016) -
The matricellular protein CCN5 prevents adverse atrial structural and electrical remodelling
por: Lee, Min‐Ah, et al.
Publicado: (2020) -
Sarcolipin Makes Heat, but Is It Adaptive Thermogenesis?
por: Campbell, Kevin L., et al.
Publicado: (2018) -
Sarcolipin Signaling Promotes Mitochondrial Biogenesis and Oxidative Metabolism in Skeletal Muscle
por: Maurya, Santosh K., et al.
Publicado: (2018)